Cloud-based software is a great industry to be in. Entertainment content provider Netflix (NASDAQ: NFLX) and CRM specialist have each given shareholders more than a 1,000% gain over the past decade. Companies that offer cloud-based solutions can provide their customers with a strong value proposition, including convenience, cost-savings, or compliance security.  For Foolish investors, these can translate into phenomenal returns.

Fittingly, there is a lot of attention on Veeva Systems (NYSE:VEEV), who is the newest player in the space. The company provides cloud-based solutions to the life sciences and pharmaceutical industry, and has already built an impressive customer list. AstraZeneca, Merck, and Pfizer are a few companies that already use its platform.

After its IPO just two months ago, Veeva looks to be in a great place to outperform. In the following video, Motley Fool Rule Breakers analyst Simon Erickson and health care bureau chief Max Macaluso break down Veeva's business and outline three metrics that investors should keep keep an eye on.


Max Macaluso, Ph.D. has no position in any stocks mentioned. Simon Erickson owns shares of Ellie Mae. Simon Erickson has the following options: short April 2014 $22.5 puts on Ellie Mae. The Motley Fool recommends Ellie Mae, Netflix, and The Motley Fool owns shares of Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.